
Laboratorios Farmaceuticos ROVI SA
MAD:ROVI

Laboratorios Farmaceuticos ROVI SA?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
46.08
91.5
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Laboratorios Farmaceuticos ROVI SA hold over its rivals?
What risks and challenges
does Laboratorios Farmaceuticos ROVI SA face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Laboratorios Farmaceuticos ROVI SA.
Provide an overview of the primary business activities
of Laboratorios Farmaceuticos ROVI SA.
What unique competitive advantages
does Laboratorios Farmaceuticos ROVI SA hold over its rivals?
What risks and challenges
does Laboratorios Farmaceuticos ROVI SA face in the near future?
Has there been any significant insider trading activity
in Laboratorios Farmaceuticos ROVI SA recently?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Laboratorios Farmaceuticos ROVI SA.
Provide P/S
for Laboratorios Farmaceuticos ROVI SA.
Provide P/E
for Laboratorios Farmaceuticos ROVI SA.
Provide P/OCF
for Laboratorios Farmaceuticos ROVI SA.
Provide P/FCFE
for Laboratorios Farmaceuticos ROVI SA.
Provide P/B
for Laboratorios Farmaceuticos ROVI SA.
Provide EV/S
for Laboratorios Farmaceuticos ROVI SA.
Provide EV/GP
for Laboratorios Farmaceuticos ROVI SA.
Provide EV/EBITDA
for Laboratorios Farmaceuticos ROVI SA.
Provide EV/EBIT
for Laboratorios Farmaceuticos ROVI SA.
Provide EV/OCF
for Laboratorios Farmaceuticos ROVI SA.
Provide EV/FCFF
for Laboratorios Farmaceuticos ROVI SA.
Provide EV/IC
for Laboratorios Farmaceuticos ROVI SA.
Show me price targets
for Laboratorios Farmaceuticos ROVI SA made by professional analysts.
What are the Revenue projections
for Laboratorios Farmaceuticos ROVI SA?
How accurate were the past Revenue estimates
for Laboratorios Farmaceuticos ROVI SA?
What are the Net Income projections
for Laboratorios Farmaceuticos ROVI SA?
How accurate were the past Net Income estimates
for Laboratorios Farmaceuticos ROVI SA?
What are the EPS projections
for Laboratorios Farmaceuticos ROVI SA?
How accurate were the past EPS estimates
for Laboratorios Farmaceuticos ROVI SA?
What are the EBIT projections
for Laboratorios Farmaceuticos ROVI SA?
How accurate were the past EBIT estimates
for Laboratorios Farmaceuticos ROVI SA?
Compare the revenue forecasts
for Laboratorios Farmaceuticos ROVI SA with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Laboratorios Farmaceuticos ROVI SA and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Laboratorios Farmaceuticos ROVI SA against its competitors.
Analyze the profit margins
(gross, operating, and net) of Laboratorios Farmaceuticos ROVI SA compared to its peers.
Compare the P/E ratios
of Laboratorios Farmaceuticos ROVI SA against its peers.
Discuss the investment returns and shareholder value creation
comparing Laboratorios Farmaceuticos ROVI SA with its peers.
Analyze the financial leverage
of Laboratorios Farmaceuticos ROVI SA compared to its main competitors.
Show all profitability ratios
for Laboratorios Farmaceuticos ROVI SA.
Provide ROE
for Laboratorios Farmaceuticos ROVI SA.
Provide ROA
for Laboratorios Farmaceuticos ROVI SA.
Provide ROIC
for Laboratorios Farmaceuticos ROVI SA.
Provide ROCE
for Laboratorios Farmaceuticos ROVI SA.
Provide Gross Margin
for Laboratorios Farmaceuticos ROVI SA.
Provide Operating Margin
for Laboratorios Farmaceuticos ROVI SA.
Provide Net Margin
for Laboratorios Farmaceuticos ROVI SA.
Provide FCF Margin
for Laboratorios Farmaceuticos ROVI SA.
Show all solvency ratios
for Laboratorios Farmaceuticos ROVI SA.
Provide D/E Ratio
for Laboratorios Farmaceuticos ROVI SA.
Provide D/A Ratio
for Laboratorios Farmaceuticos ROVI SA.
Provide Interest Coverage Ratio
for Laboratorios Farmaceuticos ROVI SA.
Provide Altman Z-Score Ratio
for Laboratorios Farmaceuticos ROVI SA.
Provide Quick Ratio
for Laboratorios Farmaceuticos ROVI SA.
Provide Current Ratio
for Laboratorios Farmaceuticos ROVI SA.
Provide Cash Ratio
for Laboratorios Farmaceuticos ROVI SA.
What is the historical Revenue growth
over the last 5 years for Laboratorios Farmaceuticos ROVI SA?
What is the historical Net Income growth
over the last 5 years for Laboratorios Farmaceuticos ROVI SA?
What is the current Free Cash Flow
of Laboratorios Farmaceuticos ROVI SA?
Discuss the annual earnings per share (EPS)
trend over the past five years for Laboratorios Farmaceuticos ROVI SA.
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
ES |
![]() |
Laboratorios Farmaceuticos ROVI SA
MAD:ROVI
|
2.6B EUR | 3.5 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
797.8B USD | 17.5 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 578.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
372.6B USD | 4.2 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2T DKK | 6.8 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
214.2B CHF | 3.5 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
189.9B CHF | 4.4 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
163.5B GBP | 4 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
212.7B USD | 3.3 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD | 70.5 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
136.5B USD | 2.2 |
|
Revenue Growth | P/S to Growth | |||||
---|---|---|---|---|---|---|
ES |
![]() |
Laboratorios Farmaceuticos ROVI SA
MAD:ROVI
|
Average P/S:
63.5
3.5
|
8%
|
0.4 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
17.5
|
23%
|
0.8 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
578.3
|
9%
|
64.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
4.2
|
4%
|
1 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
6.8
|
16%
|
0.4 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
3.5
|
5%
|
0.7 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
4.4
|
3%
|
1.5 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
4
|
7%
|
0.6 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
3.3
|
5%
|
0.7 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
70.5
|
N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
2.2
|
-1%
|
N/A |
|
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.